Ligand profile
CHEMBL3944847
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_06703 — Carbepenem-hydrolyzing beta-lactamase KPC2
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3944847- UniProt (similar protein)
Q93LQ9- pchembl
- 6.870 (~134.9 nM)
- Target protein
- KP13_06703
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 134.1
- −1 ≤ LogP ≤ 5 -0.64
- MW ≤ 500 Da 345.3
- LogP ≤ 5 -0.64
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 134.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cn1ccnc1NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)OCn1ccnc1NC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O
InChI=1S/C11H15N5O6S/c1-14-5-4-12-10(14)13-9(17)8-3-2-7-6-15(8)11(18)16(7)22-23(19,20)21/h4-5,7-8H,2-3,6H2,1H3,(H,12,13,17)(H,19,20,21)/t7-,8+/m1/s1InChI=1S/C11H15N5O6S/c1-14-5-4-12-10(14)13-9(17)8-3-2-7-6-15(8)11(18)16(7)22-23(19,20)21/h4-5,7-8H,2-3,6H2,1H3,(H,12,13,17)(H,19,20,21)/t7-,8+/m1/s1
RGYIHQTXVFPMOU-SFYZADRCSA-NRGYIHQTXVFPMOU-SFYZADRCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Activity
- 215038.0
- Binding sites
- PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3944847 →
- UniProt UniProt Q93LQ9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3944847”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_06703.
PDB 36
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).